Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Canadian Cancer"
Count: 359
Selected: 0
NCT IDTitle
NCT05640999Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT03784755Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer
NCT03624543CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
NCT03385655Prostate Cancer Biomarker Enrichment and Treatment Selection
NCT04224974Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
NCT04442048Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
NCT03568422CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
NCT03550391Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
NCT02821013Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT06235697Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
NCT04663997177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
NCT04093167Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC
NCT02512965Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases
NCT03488693Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
NCT05451004SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
NCT03461952Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)
NCT04918186Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
NCT06205485Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
NCT00482677Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
NCT02784171Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
NCT05470010Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors
NCT01658930Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT02719977A Phase I Study of CX5461
NCT02033993Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.
NCT06182774Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
NCT00993655Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
NCT00754845Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
NCT01101438A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
NCT05371808Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
NCT02597062High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT02285816MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours
NCT01396408A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
NCT05601440Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
NCT05180097Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
NCT03297606Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
NCT05998642Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
NCT05605509RP-6306 in Patients With Advanced Cancer
NCT05714891Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer
NCT04650581Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
NCT03057106Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
NCT06043427Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
NCT04161248Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
NCT03259035NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
NCT02905318Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02537418Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
NCT02511522Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
NCT02436707Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
NCT02414022Economic Analysis of Alliance A041202 CLL Study
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer